Amgen, Inc. (AMGN)
377.35
-5.12
(-1.34%)
USD |
NASDAQ |
Sep 11, 16:00
377.81
+0.46
(+0.12%)
After-Hours: 20:00
Amgen Price : 377.35 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 386.14 | 386.99 | 377.22 | 377.35 | 2.273M |
| Sep 10, 2026 | 387.84 | 391.67 | 381.51 | 382.47 | 3.432M |
| Sep 09, 2026 | 393.06 | 395.55 | 389.28 | 391.27 | 2.923M |
| Sep 08, 2026 | 408.90 | 410.02 | 391.17 | 393.17 | 6.832M |
| Sep 04, 2026 | 437.03 | 441.85 | 435.00 | 437.23 | 1.656M |
| Sep 03, 2026 | 445.67 | 445.82 | 438.08 | 444.12 | 1.842M |
| Sep 02, 2026 | 440.65 | 445.57 | 435.00 | 442.84 | 2.286M |
| Sep 01, 2026 | 435.30 | 438.65 | 431.00 | 438.12 | 2.359M |
| Aug 31, 2026 | 428.59 | 431.85 | 426.00 | 429.88 | 2.343M |
| Aug 28, 2026 | 437.89 | 437.89 | 430.72 | 432.42 | 1.740M |
| Aug 27, 2026 | 433.08 | 442.13 | 431.01 | 436.99 | 1.763M |
| Aug 26, 2026 | 441.00 | 442.88 | 438.24 | 440.34 | 2.290M |
| Aug 25, 2026 | 443.26 | 447.03 | 441.26 | 442.24 | 2.101M |
| Aug 24, 2026 | 440.31 | 445.87 | 435.51 | 443.84 | 2.464M |
| Aug 21, 2026 | 431.72 | 440.51 | 429.38 | 439.33 | 2.115M |
| Aug 20, 2026 | 435.78 | 441.34 | 431.07 | 433.73 | 2.914M |
| Aug 19, 2026 | 430.24 | 443.20 | 429.38 | 442.36 | 2.544M |
| Aug 18, 2026 | 421.64 | 427.39 | 420.72 | 425.28 | 2.592M |
| Aug 17, 2026 | 412.98 | 419.60 | 410.40 | 419.38 | 2.881M |
| Aug 14, 2026 | 413.76 | 416.03 | 410.50 | 415.21 | 2.037M |
| Aug 13, 2026 | 419.92 | 420.26 | 415.78 | 417.84 | 2.778M |
| Aug 12, 2026 | 413.31 | 418.19 | 409.00 | 416.18 | 2.066M |
| Aug 11, 2026 | 415.52 | 421.79 | 412.20 | 414.30 | 2.030M |
| Aug 10, 2026 | 408.46 | 417.36 | 406.42 | 417.20 | 1.960M |
| Aug 07, 2026 | 404.09 | 411.60 | 401.07 | 410.94 | 1.822M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 143.72 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
| AbbVie, Inc. | 257.12 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Biogen, Inc. | 217.15 |
Price Related Metrics
| PE Ratio | 23.44 |
| PS Ratio | 5.366 |
| PEG Ratio | 0.7394 |
| Price to Book Value | 17.45 |
| Price to Free Cash Flow | 20.15 |
| Earnings Yield | 4.27% |
| Market Cap | 204.00B |
| PEGY Ratio | 0.6827 |
| Operating PE Ratio | 16.11 |
| Normalized PE Ratio | 21.39 |